Firms & Funds Life Science Venture Capital: A Case for Europe – Staff Writer - 1 October 2004 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in
